Health Canada Approves Animas IR 1200 Insulin Pump for Distribution

Share Article

Health Canada Approves Animas IR 1200 Insulin Pump

Animas Corporation (Nasdaq: PUMP), a leading manufacturer of insulin pumps, announced that Health Canada has approved the distribution of the Animas IR 1200 insulin pump in Canada.

The IR 1200 pump received approval from the U.S. Food and Drug Administration in November 2003, and has been available in the U.S. since April 2004. The IR 1200 is now available in Canada, and is distributed by Auto Control Medical, Animas' exclusive Canadian distributor.

The IR 1200 is the smallest full feature pump on the market today, offering a large viewing screen, long battery life, precise insulin delivery, enhanced waterproof integrity and ease-of-use.

"We're very excited that Canadians can now benefit from the smart technology, intuitive features and reliability of our latest generation pump," explains Dr. Katherine Crothall, CEO of Animas Corporation. "Auto Control's long tenure in the diabetes industry coupled with their reputation for excellent service provides us with a strong presence in Canada, and positions us for a highly successful launch of the IR 1200 in Canada."

"The IR 1200 exceptional reputation has preceded its availability in the Canadian marketplace. It is recognized for its unparalleled ease-of-use, reliability and performance, and we are delighted that it will now be available to our patients," says Grant Reynolds, CEO of Auto Control.

An insulin pump is a pager-sized device that delivers a continuous, variable flow of insulin. Compared to insulin injections, the pump can more precisely match the often-changing insulin requirements of patients. The ability to adjust the amount of insulin by simply pressing a few buttons allows users to live a more active, flexible lifestyle with significant improvement in quality of life and blood glucose control. For more information about the Animas IR 1200, visit Auto Control Medical's web site http://www.autocontrol.com

About Animas Corporation:

Animas, a leading maker of insulin infusion pumps and related products, is dedicated to improving diabetes management and making insulin pump therapy easier for patients with insulin requiring diabetes and healthcare professionals through product innovation, exemplary customer support and superior customer education. For more information on Animas, visit http://www.animascorp.com.

About Auto Control Medical Inc.:

Auto Control Medical, with offices in Toronto and Montreal, distributes a full line of advanced electronic blood pressure monitoring equipment, diabetes management products and health care products for home and professional use. More information on Auto Control Medical and their product line is available on the company's web site, located at http://www.autocontrol.com.

Contact:

Patricia Clune

Auto Control Medical Inc.

1-800-461-0991 ext. 241

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patty Clune
Visit website